Pfizer’s Adwords run afoul of FDA regulations

John Mack is on the case:

Once again, like the Lunesta bAdword, these ads appear to violate FDA regulations regarding DTC advertising; namely, that whenever an Rx brand name and its indication are mentioned in the same ad, fair balance or the brief summary of the package insert must also be included. Generally, on the Internet, that means a direct link to the package insert. There is no such link in the above ad.

Related posts:

1. Peter Rost piles on Pfizer
2. Avandia: Patients partly to blame?
3. Internet cafes and unsafe sex
4. The case for balance billing
5. Note to politicians: Balance billing is essential
6. ER nurses and childbirth
7. Are generic medications as good as their brand name counterparts?

  Follow on Twitter   Subscribe